172 related articles for article (PubMed ID: 9730910)
21. Dopamine as a novel antimigration and antiproliferative factor of vascular smooth muscle cells through dopamine D1-like receptors.
Yasunari K; Kohno M; Hasuma T; Horio T; Kano H; Yokokawa K; Minami M; Yoshikawa J
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3164-73. PubMed ID: 9409307
[TBL] [Abstract][Full Text] [Related]
22. Trapidil inhibits platelet-derived growth factor-induced migration via protein kinase A and RhoA/Rho-associated kinase in rat vascular smooth muscle cells.
Ishikura K; Fujita H; Hida M; Awazu M
Eur J Pharmacol; 2005 May; 515(1-3):28-33. PubMed ID: 15894306
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II inhibits rat arterial KATP channels by inhibiting steady-state protein kinase A activity and activating protein kinase Ce.
Hayabuchi Y; Davies NW; Standen NB
J Physiol; 2001 Jan; 530(Pt 2):193-205. PubMed ID: 11208968
[TBL] [Abstract][Full Text] [Related]
24. Type 1 angiotensin receptor (AT1-R)-mediated decrease in type 2 angiotensin receptor mRNA level is dependent on Gq and extracellular signal-regulated kinase 1//2 in AT1-R-transfected PC12 cells.
Saito M; Shinohara Y; Sasaki H; Netsu Y; Yoshida M; Nakahata N
J Neuroendocrinol; 2008 Mar; 20(3):299-308. PubMed ID: 18208547
[TBL] [Abstract][Full Text] [Related]
25. PDGF-BB enhances monocyte chemoattractant protein-1 mRNA stability in smooth muscle cells by downregulating ribonuclease activity.
Liu B; Poon M; Taubman MB
J Mol Cell Cardiol; 2006 Jul; 41(1):160-9. PubMed ID: 16720030
[TBL] [Abstract][Full Text] [Related]
26. Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295 cells.
Bird IM; Mason JI; Rainey WE
Endocrinology; 1994 Jun; 134(6):2468-74. PubMed ID: 8194473
[TBL] [Abstract][Full Text] [Related]
27. Antisense inhibition of AT1 receptor in vascular smooth muscle cells using adeno-associated virus-based vector.
Mohuczy D; Gelband CH; Phillips MI
Hypertension; 1999 Jan; 33(1 Pt 2):354-9. PubMed ID: 9931129
[TBL] [Abstract][Full Text] [Related]
28. Regulation of angiotensin AT1 receptor gene expression during cell growth of vascular smooth muscle cells.
Nickenig G; Sachinidis A; Ko Y; Vetter H
Eur J Pharmacol; 1996 Feb; 297(3):307-12. PubMed ID: 8666064
[TBL] [Abstract][Full Text] [Related]
29. 13-cis-Retinoic acid specific down-regulation of angiotensin type 1 receptor in rat liver epithelial and aortic smooth muscle cells.
Snyder R; Thekkumkara T
J Mol Endocrinol; 2012 Apr; 48(2):99-114. PubMed ID: 22180636
[TBL] [Abstract][Full Text] [Related]
30. Platelet-derived growth factor inhibits alpha1D-adrenergic receptor expression in vascular smooth muscle cells in vitro and ex vivo.
Xin X; Yang N; Faber JE
Mol Pharmacol; 1999 Dec; 56(6):1143-51. PubMed ID: 10570041
[TBL] [Abstract][Full Text] [Related]
31. Ets-1 is an early response gene activated by ET-1 and PDGF-BB in vascular smooth muscle cells.
Naito S; Shimizu S; Maeda S; Wang J; Paul R; Fagin JA
Am J Physiol; 1998 Feb; 274(2):C472-80. PubMed ID: 9486138
[TBL] [Abstract][Full Text] [Related]
32. Regulation of vascular type 1 angiotensin receptors by cytokines.
Sasamura H; Nakazato Y; Hayashida T; Kitamura Y; Hayashi M; Saruta T
Hypertension; 1997 Jul; 30(1 Pt 1):35-41. PubMed ID: 9231818
[TBL] [Abstract][Full Text] [Related]
33. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
Kim TJ; Yun YP
Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883
[TBL] [Abstract][Full Text] [Related]
34. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle.
Wang CH; Li SH; Weisel RD; Fedak PW; Dumont AS; Szmitko P; Li RK; Mickle DA; Verma S
Circulation; 2003 Apr; 107(13):1783-90. PubMed ID: 12665485
[TBL] [Abstract][Full Text] [Related]
35. Protein kinase C-dependent regulation of the human AT1 promoter in vascular smooth muscle cells.
Holzmeister J; Graf K; Warnecke C; Fleck E; Regitz-Zagrosek V
Am J Physiol; 1997 Aug; 273(2 Pt 2):H655-64. PubMed ID: 9277481
[TBL] [Abstract][Full Text] [Related]
36. Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms.
Nickenig G; Röling J; Strehlow K; Schnabel P; Böhm M
Circulation; 1998 Dec; 98(22):2453-60. PubMed ID: 9832492
[TBL] [Abstract][Full Text] [Related]
37. Parathyroid hormone (PTH)/PTH-related protein (PTHrP) receptor and its messenger ribonucleic acid in rat aortic vascular smooth muscle cells and UMR osteoblast-like cells: cell-specific regulation by angiotensin-II and PTHrP.
Okano K; Wu S; Huang X; Pirola CJ; Juppner H; Abou-Samra AB; Segre GV; Iwasaki K; Fagin JA; Clemens TL
Endocrinology; 1994 Sep; 135(3):1093-9. PubMed ID: 8070351
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells.
Briand V; Riva L; Galzin AM
Br J Pharmacol; 1994 Aug; 112(4):1195-201. PubMed ID: 7952881
[TBL] [Abstract][Full Text] [Related]
39. cAMP attenuates angiotensin-II-induced Egr-1 expression via PKA-dependent signaling pathway in vascular smooth muscle cells.
Simo-Cheyou ER; Youreva V; Srivastava AK
Can J Physiol Pharmacol; 2017 Aug; 95(8):928-937. PubMed ID: 28460186
[TBL] [Abstract][Full Text] [Related]
40. Rapid activation of the novel serine/threonine protein kinase, protein kinase D by phorbol esters, angiotensin II and PDGF-BB in vascular smooth muscle cells.
Abedi H; Rozengurt E; Zachary I
FEBS Lett; 1998 May; 427(2):209-12. PubMed ID: 9607313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
